North America Atrial Fibrillation Market Trends, Growth, Size, Analysis and Forecast by 2027 with CAGR of 13.7%

Atrial fibrillation is the heart rate that occurs when two upper chambers of your heart are marked by very aggressive electrical signals. The result is a quick and uncomplicated heartbeat. The heart rate in atrial fibrillation ranges from 100 to 175 beats per minute.

The healthcare industry is undergoing rapid transformations since a few years now. Various technological improvements have been witnessed in the segments including diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses and the increasing ageing population are the primary factors fuelling the growth of healthcare segment.

The North America Atrial Fibrillation market is growing along with the healthcare industry, but the market is likely to slow down its growth due to the shortage of skilled professionals, suggests the Business Market Insights report.

The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.

Get Sample PDF of the report at –

Other than bodies such as associations and organizations, companies in the market have also played an instrumental role in increasing the awareness regarding atrial fibrillation. For instance, Biosense Webster, a Division of Johnson & Johnson, launched two major initiatives as a part of the Global AF Aware Week, which falls between 18–24 November. As a part of the action named Get Smart About AFIB (GSAAF), the company entered into a strategic partnership with the Arrhythmia Alliance to increase knowledge of AF across the healthcare community and the general public.

These factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for North America Atrial Fibrillation assays in the market.

Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.
Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.

North America Atrial Fibrillation – MARKET SEGMENTATION
By Treatment
• Non – pharmacological
• MAZE Surgery
• Catheter Ablation
• Electric Cardioversion
• Pharmacological
• Anti-arrhythmic Drugs
• Anti-coagulant Drugs

By End User
• Hospitals
• Ambulatory Surgical Centers,
• Cardiac Catheterization Laboratories

By Geography
• North America
• US
• Canada
• Mexico

Company Profiles
• Boston Scientific Corporation
• Medtronic
• AtriCure, Inc
• CardioFocus
• Abbott
• Sanofi
• Bristol-Myers Squibb Company
• Biotronik, Inc
• Biosense Webster, Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact US:

Business Market Insights

Phone: +442081254005

E-Mail ID: [email protected]

Web URL:

LinkedIn URL:

Leave a Reply

Your email address will not be published.